Clinical Trial Update: Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. [NA]

View source ↗

Summary

A clinical trial evaluating UroLift before SBRT to reduce urinary toxicity in patients with benign prostatic hyperplasia and prostate cancer is currently suspen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Drugs mentioned

• UroLift System

Snippet

Sponsor: Northwell Health | Conditions: Benign Prostatic Hyperplasia | NA | Status: SUSPENDED